Therapeutic apheresis

Lipoprotein apheresis
Lipoprotein apheresis aims to substantially reduce high cholesterol levels and other harmful lipoproteins in the patient’s bloodstream by using direct adsorption or filtration technologies. DALI® lipoprotein apheresis is used to treat patients with severe hypercholesterolemia and/or elevated levels of lipoprotein(a) [Lp(a)].

Key features:

  • Highly selective LDL-C and Lp(a) removal
  • Significantly effective in the reduction of LDL-C and Lp(a)
  • Short treatment time
  • Simple treatment procedure
By continuing on this website you accept the use of cookies on your device as described in the Privacy Policy.